Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pleural mesotheliomas. Current knowledge].

C Evrard1, P Icard, J P Le Rochais

  • 1Service de Chirurgie Thoracique et Cardio-Vasculaire, Centre Hospitalier Universitaire de Caen.

Annales De Chirurgie
|May 18, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apilimod in oncology: From non-malignant origins to emerging anti-cancer potential.

European journal of pharmacology·2026
Same author

Molecular analysis in pancreatic adenocarcinoma: a real-world study from high-volume French centres (CAPANCOBIO study).

ESMO gastrointestinal oncology·2026
Same author

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.

International journal of surgery (London, England)·2024
Same author

Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer.

ESMO open·2021
Same author

Use of Tenax® films to demonstrate the migration of chemical contaminants from cardboard into dry food.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2017
Same author

How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

Oncogene·2014
Same journal

[The prevention of intestinal obstruction related to adhesions].

Annales de chirurgie·2006
Same journal

WITHDRAWN: Et maintenant une revue unique : le nouveau Journal de chirurgie WITHDRAWN: And now a single journal, the new "Journal of surgery"

Annales de chirurgie·2006
Same journal

[Results of resection for ductal adenocarcinoma of the pancreatic head].

Annales de chirurgie·2006
Same journal

[Results of pancreatic cancer surgery].

Annales de chirurgie·2006
Same journal

[Results of resection of locally recurrent rectal cancer].

Annales de chirurgie·2006
Same journal

[Reconstruction after pancreaticoduodenectomy: Pancreaticojejunostomy or pancreaticogastrostomy?].

Annales de chirurgie·2006
See all related articles

Pleural mesotheliomas, rare primary tumors, are classified into benign, localized malignant, and diffuse malignant types. Diffuse malignant mesothelioma has a poor prognosis despite multimodal therapy, necessitating improved treatment strategies.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pathology

Context:

  • Pleural mesotheliomas are rare primary neoplasms originating in the pleura.
  • Three distinct classifications exist: benign, localized malignant (fibrosarcoma), and diffuse malignant (epithelial type).
  • Diffuse malignant mesothelioma presents a poor prognosis despite current therapeutic interventions.

Purpose:

  • To classify pleural mesotheliomas and outline their distinct therapeutic approaches and prognoses.
  • To review current surgical options for diffuse malignant mesothelioma, including extrapleural pneumonectomy and pleurectomy/decortication.
  • To emphasize the need for rigorous multimodality therapy to enhance survival and local control.

Summary:

  • Benign pleural mesothelioma is curable with complete surgical resection.

Related Experiment Videos

  • Localized malignant mesothelioma, a fibrosarcoma, is best managed with wide en-bloc resection.
  • Diffuse malignant mesothelioma, predominantly epithelial, shows limited long-term survival despite combined modality treatments (surgery, irradiation, chemotherapy).

    • Impact:

    • Highlights the challenges in treating diffuse malignant mesothelioma, underscoring the need for advanced therapeutic strategies.
    • Provides a classification framework for pleural mesotheliomas, aiding in diagnosis and treatment planning.
    • Emphasizes the critical role of multimodal therapy in improving outcomes for patients with this rare malignancy.